General Information of the Compound
| Compound ID |
CP0848532
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-3-[3-(2-{[5-methyl-2-(methyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C40H39F2N7O2
|
||||||||||||||||||
| Molecular Weight |
687.795
|
||||||||||||||||||
| Canonical SMILES |
CCCN1CCC(c2cc(OC)c(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6c(F)cccc6F)c5)nc5ccccn45)n3)cc2C)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C40H39F2N7O2/c1-4-18-48-20-15-26(16-21-48)29-24-34(51-3)33(22-25(29)2)45-40-43-17-14-32(44-40)38-36(46-35-13-5-6-19-49(35)38)27-9-7-10-28(23-27)39(50)47-37-30(41)11-8-12-31(37)42/h5-14,17,19,22-24,26H,4,15-16,18,20-21H2,1-3H3,(H,47,50)(H,43,44,45)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HTPGJCKRTDSLJM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor